Project Grant R01AG091334
- Federal Project Grant Award Summary The University of Pennsylvania received a $613,823 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), effective September 1, 2025, through August 31, 2030. The award funds the SENSE4SAFETY intervention, a technology-supported fall risk reduction initiative designed specifically for community-dwelling older adults aged 65 and older with mild cognitive impairment (MCI). The project delivers three integrated...
- Federal Project Grant Summary The National Institute on Aging (NIA) awarded a $2.7 million Project Grant to the University of California, Los Angeles under the Aging Research program (CFDA 93.866) for the period September 1, 2025 through August 31, 2029. This research project will generate evidence-based comparative outcome data examining post-acute care discharge destinations for older patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD). The research will...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded the University of Colorado-Denver a Project Grant of $634,658 on February 15, 2026, under the Aging Research program (CFDA 93.866), with a completion date of November 30, 2030. The research project investigates the interaction between systemic endothelial glycocalyx fragility and brain dysfunction in aged sepsis survivors. The study addresses a critical public health challenge, as sepsis affects nearly 50 million...
- Federal Grant Award Summary The National Institute on Aging awarded a $1,170,020 Project Grant to The Leland Stanford Junior University effective June 1, 2025, through February 28, 2030, under the Aging Research program (CFDA 93.866). The EMERGED (Enhancing the Implementation, Effectiveness, and Reach of Geriatric Emergency Departments for Older Adults with Dementia) project will deliver comprehensive research and implementation guidance designed to improve emergency department care for older...
- Federal Grant Award Summary The National Institute on Aging awarded a $627,916 Project Grant to Kaiser Foundation Hospitals (Kaiser Permanente) on September 15, 2025, under the Aging Research program (CFDA 93.866) to investigate missed home health care (HHC) in older adults with Alzheimer's disease and related dementias. This five-year study (completion date June 30, 2030) employs mixed methods research to identify key drivers and mitigators of missed HHC following hospital discharge,...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded the Regents of the University of Michigan a $422,319 Project Grant on September 15, 2025, under the Aging Research program (CFDA 93.866) to develop and test implementation strategies for an adapted Community Care Transition Initiative (CCTI-ADRD) targeting rural older adults with Alzheimer's disease and related dementias (ADRD) and their care partners. The project, which runs through September 14, 2027, will deliver a...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded the University of Delaware a $2.61 million Project Grant under the Aging Research program (CFDA 93.866) effective September 1, 2025, through August 31, 2029. This research initiative will generate evidence-based knowledge regarding the safety and effectiveness of hypertension treatment strategies for nursing home residents with Alzheimer's disease and related dementias (ADRD). The project addresses a critical gap in...
- Federal Grant Award Summary The University of Colorado-Denver received a $4.65 million Project Grant award effective September 1, 2025, through August 31, 2029, under the Special Programs for the Aging, Title IV, and Title II, Discretionary Projects program (CFDA 93.048), administered by the Administration for Community Living. The grant funds the STEP in Colorado (Scaling Trusted Evidence-Based Prevention in Colorado) initiative, a four-year statewide effort implemented in partnership with...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded $204,806 to the University of Colorado-Denver on August 15, 2025, under the Aging Research program (CFDA 93.866) to support a five-year research project extending through July 31, 2030. The award funds the TIME2CONNECT study, which aims to adapt and test an evidence-based creative storytelling intervention called TIMESLIPS for older adults with mild cognitive impairment (MCI) or mild Alzheimer's disease and related...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded the University of North Carolina at Chapel Hill $843,404 on September 15, 2025, under the Aging Research program (CFDA 93.866) to conduct a clinical trial addressing disparities in goals-of-care communication for Alzheimer's disease and related dementias (ADRD) nursing home care at end of life. The GOC Advance (Goals of Care—Addressing Variation for Alzheimer's Disease Nursing Home Care at End of Life) initiative will...
The National Institute on Aging (NIA) awarded a $783,984 Project Grant to The Regents of the University of Colorado (University of Colorado-Denver) on March 15, 2026, under the Aging Research program (CFDA 93.866) to support the GAPCAREAD multisite randomized controlled trial (RCT). This five-year initiative, extending through February 28, 2031, will test the efficacy of an adapted emergency department (ED)-based fall prevention intervention for 350 persons living with dementia (PLWD) and their caregivers presenting to the ED following a fall. The GAPCAREAD intervention leverages an established fall prevention protocol by coordinating medication therapy management performed by pharmacists, brief physical therapy assessments and mobility improvement plans conducted by physical therapists, and electronically transmitted action plans co-created with patients and caregivers that are shared with outpatient clinicians at discharge. Building upon prior successful research demonstrating 66% fewer fall-related ED visits at six months, this project delivers evidence-based clinical services and research outcomes designed to address a significant care gap for persons living with Alzheimer's disease and related dementias who experience disproportionately high fall rates, fall-related treatment costs, and adverse outcomes following ED visits. The grant supports rigorous clinical trial infrastructure, interdisciplinary team collaboration, and implementation of a dementia-adapted intervention tailored through prior patient and caregiver feedback to enhance post-fall care coordination and fall prevention outcomes in this vulnerable population.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $784.0k | 3/12/26 |